Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Glufosfamide

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 101,450Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eleison to Partner China Oncology Focus an Affiliate of Lee’s for Glufosfamide
    Eleison to Partner China Oncology Focus an Affiliate of Lee’s for Glufosfamide

    21 Nov 2017

    // PRESS RELEASE

    http://www.eleison-pharma.com/cushy_uploads/news_32_4097612997.pdf

    PRESS RELEASE
    21 Nov 2017
    Share Share
    Eleison Announces Approval from CFDA to Expand Eleison’s PhIII Glufosfamide
    Eleison Announces Approval from CFDA to Expand Eleison’s PhIII Glufosfamide

    16 May 2016

    // PRESS RELEASE

    http://www.eleison-pharma.com/cushy_uploads/news_30_1180908512.pdf

    PRESS RELEASE
    16 May 2016
    Share Share
    Eleison Announces the Issuance of New Patents for Glufosfamide and ILC
    Eleison Announces the Issuance of New Patents for Glufosfamide and ILC

    11 Dec 2015

    // PRESS RELEASE

    http://www.eleison-pharma.com/cushy_uploads/news_29_2036342757.pdf

    PRESS RELEASE
    11 Dec 2015
    Share Share
    Eleison Announces Agreement with FDA on a SPA for a Ph3 Glufosfamide
    Eleison Announces Agreement with FDA on a SPA for a Ph3 Glufosfamide

    26 May 2010

    // PRESS RELEASE

    http://www.eleison-pharma.com/cushy_uploads/news_5_2316371766.pdf

    PRESS RELEASE
    26 May 2010
    Share Share